Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision
Thousands still not warned of hepatitis exposure at Las Vegas clinics  - 22 May, 2008
Two Las Vegas clinics are linked to an outbreak of hepatitis C and HIV. The Nevada Health District sent more than 40,000 "Dear Patient" letters to those treated after March 2004 . Patients treated before March 2004 have not been warned that they are at risk of infection of these contagious diseases.

Mains Associates Profiles High-Value Benefits from Taxpayer-Funded Research  - 21 May, 2008
Mains Associates now provides access to a science knowledge base highlighting NASA's research contributions to challenges in the biosciences related to space exploration. Many of these results can also benefit the ultimate funders of this research, the public.

More than 100 Leading Organizations from Around the World to Convene in...  - 20 May, 2008
Biodetection Technologies is an internationally recognized event for experts in detection and identification of biological and chemical threats. Delivering this year's opening keynote address will be Robert Hooks, the Deputy Assistant Secretary for WMD and Biodefense from the U.S. Department of Homeland Security.

Take A Seat  - 20 May, 2008
Online Public Restroom Finder Offers Women Options….And, Relief!

Highest Replikin Concentrations and Cyclical Behavior Related to Human...  - 19 May, 2008
Replikins Ltd. has found that very high concentrations of its replikin genetic sequences are found in the trypanosomes that are the infectious agents in malaria. The levels found by the company are in fact the highest replikin concentrations observed to date in any infectious disease agent. The company has also found that these concentrations cycle over several years.

Dynavax to Discuss TOLAMBATM Chamber Data; Update 2008 Outlook in Webcast...  - 16 May, 2008
BERKELEY, Calif. (Business Wire EON) May 16, 2008 -- Dynavax Technologies (Nasdaq:DVAX) will webcast this morning a discussion of the TOLAMBA Chamber study data and provide an updated financial outlook for 2008.

Dynavax TOLAMBA™ Chamber Study Misses Primary Endpoint; Company...  - 16 May, 2008
BERKELEY, Calif. (Business Wire EON) May 16, 2008 -- Dynavax Technologies Corporation (Nasdaq:DVAX) today reported primary endpoint data from a chamber study of TOLAMBA™ that showed a measurable clinical benefit, reducing total nasal symptom score (TNSS) by 41% vs. placebo in 253 patients in the intent-to-treat population (p=0.09) and by 51% vs. placebo in 222 patients in the per-protocol population (p=0.053). Statistical significance on the primary efficacy endpoint (change in TNSS for the intent-to-treat population) for this Phase 2b environmental exposure chamber (EEC) study was...

IBJI Physicians Discover Link To Post Op Infections  - 15 May, 2008
Illinois Bone and Joint Institute (IBJI) physicians associated with Evanston Northwestern Hospital (ENH) have discovered a link between nasal staff bacteria and post-surgical infections.

Malaria Warning: Malaria Myths Put Travellers Visiting Friends and Relatives...  - 15 May, 2008
Thousands of UK residents could be exposing themselves to the potentially deadly disease, malaria, a new survey reveals today.

Malaria Warning To Business Travellers -- Malaria myths are putting...  - 15 May, 2008
Black & Asian business travellers from the UK could be exposing themselves to the deadly disease, malaria, after a new survey revealed that 50% of travellers who originate from a malarious area believe they have natural immunity when travelling to a country with a malaria risk.1
Previous page 1 2 3 4 5 6 7 8 9 Next page
Home Terms of Use Privacy Policy Contact Us